eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2022, Volume 18, Issue 2 : 51-55
Research Article
Personalized Healthcare Using Genomic Data: Advancing Precision Medicine Through Genomic Innovation
 ,
 ,
 ,
1
Department of Genomic Medicine, Global Institute of Precision Health, Boston, USA
2
Department of Medical Genetics and Bioinformatics, International Medical Sciences University, New Delhi, India
3
Center for Personalized Medicine Research, University of Melbourne, Australia
4
Department of Molecular Medicine and Healthcare Innovation, Emirates Medical Research Institute, Dubai, UAE
Received
Aug. 18, 2022
Revised
Sept. 29, 2022
Accepted
Nov. 11, 2022
Published
Dec. 21, 2022
Abstract

Advances in genomic technologies have transformed healthcare by enabling personalized approaches to disease prevention, diagnosis, and treatment. Personalized healthcare utilizes genomic information alongside clinical, environmental, and lifestyle data to optimize healthcare interventions for individual patients. The integration of genomic data into clinical practice represents a cornerstone of precision medicine.ObjectiveThis study examines the role of genomic data in personalized healthcare, evaluates current applications, discusses benefits and challenges, and explores future directions in precision medicine.MethodsA narrative review of literature published between 2018 and 2025 was conducted using PubMed, Scopus, Web of Science, Embase, and Google Scholar. Studies focusing on genomics, pharmacogenomics, precision medicine, genetic testing, and personalized healthcare interventions were included.ResultsGenomic data have significantly improved disease risk assessment, early diagnosis, pharmacogenomics, cancer treatment, rare disease identification, and preventive healthcare strategies. Personalized healthcare approaches demonstrate improved clinical outcomes, reduced adverse drug reactions, and enhanced treatment effectiveness. Challenges include data privacy concerns, ethical considerations, cost barriers, and healthcare infrastructure limitations.ConclusionGenomic-driven personalized healthcare is reshaping modern medicine by enabling more precise and individualized patient care. Continued advancements in genomic sequencing, bioinformatics, artificial intelligence, and healthcare integration are expected to accelerate the adoption of precision medicine globally.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
“Outcomes of TAVR vs SAVR Among High-Risk Patients”
39-42
Impact of Dual Antiplatelet Therapy Duration on Post-PCI Outcomes
11-14
Percutaneous Balloon Angioplasty as First-Line Therapy in Low-Income Patients
31-34
PCI Outcomes in Patients With Chronic Total Occlusion
14-17
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.